SHANGHAI HENLIUS BIOTECH INC. (SGBCF)
Clinical trial NCT07473726 updates: 1. start date: 2026-05-17 → 2026-06-20 2. allocation: NON_RANDOMIZED → NA
Clinical trial NCT07473726 updates: 1. start date: 2026-05-17 → 2026-06-20 2. allocation: NON_RANDOMIZED → NA
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical